Influenza Diagnostics Market Benefit and Volume 2021 with Status and Prospect to 2028 | Roche Diagnostics, Becton, Dickinson and Company

Influenza (flu) is referred to an upper respiratory system contagious disease caused by the influenza virus. Pandemic and seasonal are the two influenza types. Seasonal influenza is sub-divided into three major types, namely A, B, and C influenza. It is mainly transmitted through public places from infected person’s sneeze droplets serving as a disease carrier. As per the Centers for Disease Control and Prevention (CDC), in 2017-2018 symptomatic illnesses of over 49,000,000 and around 79,000 deaths were caused due to Influenza, in the U.S. Pregnant women, geriatrics, pediatrics, low immunity patients having chronic illness, and healthcare professionals are at a high risk of getting infected with influenza.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬

High influenza prevalence and increasing funding for influenza research diagnostics are key factors, expected to drive growth of the global influenza diagnostics market over the forecast period. As per the World Health Organization (WHO), in 2018, influenza resulted in over 3-5 million severe illness cases and over 290,000-650,000 fatalities worldwide. The National Institute of Allergy and Infectious Disease (NIAID), in 2014, partnered with The National Institutes of Health (NIH) Autoimmune Disease Coordinating Committee (ADCC) supporting The Center of Excellence in Influenza Research and Surveillance (CIERS) for the influenza virus’ better understanding. High number of influenza-prone geriatric population, increasing awareness along with great demand for more efficient and advanced diagnostic tests for influenza are expected to drive the global influenza diagnostics market growth.

𝐓𝐨 𝐆𝐞𝐭 𝐦𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐚𝐭𝐞𝐫𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 –https://www.coherentmarketinsights.com/insight/request-sample/2414

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬

North America is expected to hold a dominant position in the global influenza diagnostics market, owing to the CDC’s robust initiatives in order to control the disease spread by actively executing preventive measures along with diagnosing the disease with the help of its National Influenza Surveillance System. Increasing Rapid Diagnostic Tests (RDTs) availability has fueled these implementations further in the U.S.

Asia Pacific is projected to robust growth in the global influenza diagnostics market during the forecast period, due to countries actively participating in preventive measures for countering the influenza incidence. For instance, the CDC in 2014 funded nine cooperative agreements for non-researched-related bilateral influenza in the South-East Asian Region (SEAR), as an initiative for responding to avian, pandemic, and seasonal influenza.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Key players functioning in the global influenza diagnostics market are, Roche Diagnostics, Dickinson and Company, Becton, Thermo Fisher Scientific, Quidel Corporation, Alere, and others. Major market players are focusing on R&D activities for offering efficient and cost-effective diagnostic devices. For instance, Roche, in 2016, received the clearance from U.S. FDA and waiver from Clinical Laboratory Improvement Amendments (CLIA) for its test of cobas Influenza RSV & A/B. The test assists flu RSV and A/B molecular testing of and is used with cobas Liat system.

𝐓𝐨 𝐊𝐧𝐨𝐰 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/2414

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭

• Abbott Laboratories, in February 2019, launched reformulated Influenza test - BinaxNow A & B Card 2 rapid. It is an in vitro influenza detecting immunochromatographic assay.

• Eurofins Viracor, Inc., in February 2019, introduced a PCR test for Antiviral Resistance - baloxavir marboxil (XOFLUZA) for detecting H3N2 mutations I38T/M/F.

• Sekisui Diagnostics collaborated with Mesa Biotech, Inc., in 2018 and launched A&B test of Silaris Influenza.

• Abbott Laboratories, in 2018, acquired a service and diagnostic device provider, Alere Inc., which made the diagnostic presence of the company strong in the international market.

• Roche, in 2016, received clearance from the U.S. FDA and waiver from Clinical Laboratory Improvement Amendments (CLIA) for the real-time cobas Influenza A/B & RSV and PCR tests. The test assists flu RSV and A/B molecular testing of and is used with cobas Liat system.

𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐚𝐱𝐨𝐧𝐨𝐦𝐲
𝐁𝐚𝐬𝐞𝐝 𝐨𝐧 𝐭𝐞𝐬𝐭 𝐭𝐲𝐩𝐞,

• Traditional Diagnostic Tests

o Viral Culture
o Rapid Influenza Diagnostic Tests (RIDT)
o Serological Assays
o Direct Fluorescent Antibody (DFA) Tests

• Molecular Diagnostic Assays
o Loop-Mediated Isothermal Amplification-Based Assays (LAMP)
o RT-PCR
o Nucleic Acid Sequence-Based Amplification (NASBA) Tests
o Simple Amplification-Based Assays (SAMBA)
o Others

Based on end user,
• Reference Laboratories
• Hospitals & Clinics
• Others

Based on region,
• North America
• Europe
• Latin America
• Asia Pacific
• Africa
• Middle East

𝐓𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐚𝐧𝐝 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 – https://www.coherentmarketinsights.com/insight/buy-now/2414

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.